News
Zacks Investment Research on MSN1d
Here's Why Moderna (MRNA) Fell More Than Broader MarketModerna (MRNA) ended the recent trading session at $31.25, demonstrating a -2.95% change from the preceding day's closing price. This move lagged the S&P 500's daily loss of 0.01%. Elsewhere, the Dow ...
Moderna Reports First Quarter 2025 Financial Results and Provides Business Updates May 01, 2025 6:30 AM ET Moderna, Inc. (MRNA) ...
International Business Machines said Thursday that it had joined forces with Moderna for a case study that evidenced quantum ...
CAMBRIDGE, MA / ACCESS Newswire / May 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today reported financial results and provided business updates for the first quarter of 2025. "In the first quarter, we ...
Moderna's RSV vaccine for adults aged 60 years and older has been recently approved in Australia, Switzerland, Taiwan and the UK. First Quarter 2025 Financial Results ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback